Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Hwang

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Molecular Cancer Therapeutics|February 22, 2023
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer CellsJitender Monga, Frederick Valeriote, Clara Hwang, et al.
Clinical Therapeutics|November 15, 2011
Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trialDominick J Angiolillo, Clara Hwang, Catherine Datto, et al.
Molecular Cancer Research : MCR|July 21, 2023
A Novel Role of Prostate-Specific Membrane Antigen in Telomere Stability in Prostate Cancer CellsVidyavathi Reddy, Clara Hwang, G Prem-Veer Reddy, et al.
The Prostate|February 28, 2017
IAP Antagonists Enhance Apoptotic Response to Enzalutamide in Castration-Resistant Prostate Cancer Cells via Autocrine TNF-α SignalingAmanda B Pilling, Ok Hwang, Alain Boudreault, et al.
Expert Opinion on Pharmacotherapy|October 26, 2013
Chemotherapeutic inhibitors in the treatment of prostate cancerRahul R Deshmukh, Sara M Schmitt, Clara Hwang, et al.
Current Medical Research and Opinion|April 29, 2011
Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trialsMarc C Hochberg, John G Fort, Ola Svensson, et al.
The Prostate|January 6, 2023
Molecular features and race-associated outcomes of SPOP-mutant metastatic castration-resistant prostate cancerAndrew Stangl, Christopher Wilner, Pin Li, et al.
Clinical Genitourinary Cancer|May 18, 2025
Dose-Dense Docetaxel and Radium-223 in Bone-Dominant Metastatic Castration-Resistant Prostate CancerBrendan Connell, Clara Hwang, Edmund Folefac, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 16, 2020
Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropeniaLucas Maahs, Amy Tang, Zaid Al Saheli, et al.
Clinical Genitourinary Cancer|May 10, 2016
The Effect of Time to Castration Resistance on Outcomes With Abiraterone and Enzalutamide in Metastatic Prostate CancerJonathan Hung, Andrew R Taylor, George W Divine, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|February 22, 2023
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer CellsJitender Monga, Frederick Valeriote, Clara Hwang, et al.
Clinical Therapeutics|November 15, 2011
Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trialDominick J Angiolillo, Clara Hwang, Catherine Datto, et al.
Molecular Cancer Research : MCR|July 21, 2023
A Novel Role of Prostate-Specific Membrane Antigen in Telomere Stability in Prostate Cancer CellsVidyavathi Reddy, Clara Hwang, G Prem-Veer Reddy, et al.
The Prostate|February 28, 2017
IAP Antagonists Enhance Apoptotic Response to Enzalutamide in Castration-Resistant Prostate Cancer Cells via Autocrine TNF-α SignalingAmanda B Pilling, Ok Hwang, Alain Boudreault, et al.
Expert Opinion on Pharmacotherapy|October 26, 2013
Chemotherapeutic inhibitors in the treatment of prostate cancerRahul R Deshmukh, Sara M Schmitt, Clara Hwang, et al.
Current Medical Research and Opinion|April 29, 2011
Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trialsMarc C Hochberg, John G Fort, Ola Svensson, et al.
The Prostate|January 6, 2023
Molecular features and race-associated outcomes of SPOP-mutant metastatic castration-resistant prostate cancerAndrew Stangl, Christopher Wilner, Pin Li, et al.
Clinical Genitourinary Cancer|May 18, 2025
Dose-Dense Docetaxel and Radium-223 in Bone-Dominant Metastatic Castration-Resistant Prostate CancerBrendan Connell, Clara Hwang, Edmund Folefac, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 16, 2020
Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropeniaLucas Maahs, Amy Tang, Zaid Al Saheli, et al.
Clinical Genitourinary Cancer|May 10, 2016
The Effect of Time to Castration Resistance on Outcomes With Abiraterone and Enzalutamide in Metastatic Prostate CancerJonathan Hung, Andrew R Taylor, George W Divine, et al.
Pageof 9